Idexx Laboratories | IDXX - Current Liabilities


Idexx Laboratories reported $1.29B in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
Abbott USD 18.38B 1.88B Mar/2026
Accuray USD 199.44M 4.83M Dec/2025
Align Technology USD 1.91B 2.74M Jun/2026
AngioDynamics USD 71.96M 3.68M Sep/2025
Dentsply International USD 1.18B 22M Jun/2026
Dexcom USD 2.36B 133.9M Jun/2026
Edwards Lifesciences USD 1.51B 98.9M Jun/2026
Fujifilm JPY 1.26T 57.74B Mar/2026
Globus Medical USD 479.35M 3.12M Jun/2026
Henry Schein USD 3.49B 191M Jun/2026
Idexx Laboratories USD 1.29B 12.19M Jun/2026
Inogen USD 64.94M 2.12M Sep/2025
Insulet USD 744.2M 56.7M Jun/2026
Integra LifeSciences USD 330.88M 15.96M Jun/2026
Intuitive Surgical USD 2.58B 65.1M Jun/2026
Neogen USD 158.2M 7.6M Mar/2026
Orthofix International USD 157.01M 4.02M Jun/2026
Phibro Animal Health USD 316.47M 34.6M Jun/2026
ResMed USD 1.4B 43.9M Jun/2026
Roche Holding CHF 28.85B 846M Jun/2026
Steris USD 1.28B 138.3M Jun/2026
Tandem Diabetes Care USD 253M 5.05M Jun/2026
Teleflex USD 720.38M 7.67M Jun/2026
Thermo Fisher Scientific USD 15.07B 448M Jun/2026
Zoetis USD 2.06B 8M Jun/2026